2021 annual financial data
ImmuCell 2021 Financial results
Direct answer
Revenue was 19,242,969 USD.
Operating income was 257,385 USD and net income was -78,292 USD.
Operating cash flow was 954,170 USD.
Get free ImmuCell email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,242,969 USD
- Operating income
- 257,385 USD
- Net income
- -78,292 USD
- Operating cash flow
- 954,170 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all ImmuCell financial years